Home/ Supplements/ Melatonin/ Melatonin-SR

Melatonin-SR

product on market Capsule Quality Of Life Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

MicroActive Melatonin is a sustained-release form of melatonin designed to support sleep onset and maintenance. There is strong evidence that melatonin helps regulate sleep-wake cycles, though the specific efficacy of this micro-encapsulated delivery system has limited clinical documentation. The ingredient profile is generally recognized as safe for short-term use.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Melatonin-SR
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Vegicap(s)
Serving Size
30
Servings
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 3.0mg (984 products) 240 studies (A:2, B:109)

Other Ingredients

Cellulose L-Leucine Carnauba Wax Sodium Alginate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Warnings & Precautions

Warning: Do not use if seal is broken or missing.

Keep out of reach of children.

Consult your healthcare professional before use if you are pregnant or lactating, have or had a medical condition, or are taking prescription drugs.

Formulation Notes

Melatonin-SR is the answer! It features MicroActive Melatonin, which is made with a special sustained release matrix that releases melatonin slowly over 7 hours, helping you fall asleep, stay asleep, and wake up refreshed.

Sleep support Gradual release into the bloodstream Helps you fall asleep quickly Helps you stay asleep until dawn

7-hour sustained release

V

GF GMO

GMP

This product is suitable for vegetarians and gluten-free.

This product is suitable for vegetarians and gluten-free.

Additional Information

People who experience occasional sleeplessness generally fall into three camps: those who have trouble falling asleep, those who have difficulty sleeping through the night, and those who wake up earlier than desired. Multiple human studies have shown that melatonin - a hormone that helps regulate the sleep-wake cycle - can reduce the time it takes to fall asleep. However, because regular melatonin leaves the system within four hours, it does not help those who wake during the night or early in the morning.

Store at room temperature.

Metadata

Product Details

UPC / SKU8 12259 00353 0
DSLD Entry Date2023-11-22
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID299345
Data Updated2026-04-11
Research

Research Evidence

291
Research Sources
55
Avg Quality
129
Meta Analysis
93
Systematic Review
51
Rct
11
Clinical Trial
2
Other
2
Regulatory Source
1
Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022 PubMed DOI
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022 PubMed DOI
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023 PubMed DOI
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Melatonin →
Compare

Similar Products

View all Melatonin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.